poster

Relapse in Adequately Versus Not Adequately Treated Female Patients With Schizophrenia Who Transitioned to Once-Every-3-Months Paliperidone Palmitate Injections: A Retrospective Claims Database Study

Abstract: Purpose: Paliperidone palmitate once-every-3-months (PP3M) is a long-acting injectable antipsychotic indicated for adults with schizophrenia adequately treated (AT) with once-mo...

01/19/2023

Tardive Dyskinesia: Epidemiological Trends in US Populations Based on Cross-Sectional Analysis of Retrospective Claims Data

Abstract: Background: Tardive dyskinesia (TD), an iatrogenic movement disorder associated with antipsychotic agent (AP) use, is predicted to increase in prevalence, but real-world data ar...

01/19/2023

Healthcare Resource Utilization 6 Weeks Post-Diagnosis Among Individuals With Major Depressive Disorder in the United States

Abstract: Background: Although major depressive disorder (MDD) is associated with high economic burden, short-term healthcare resource utilization (HCRU) is poorly understood in patients ...

01/19/2023

A Model-Based Pharmacokinetic Comparison of Delayed-Release/Extended-Release Methylphenidate to Extended-Release Methylphenidates with Immediate-Release Supplementation

Abstract: Purpose: Immediate-release methylphenidate (IR MPH) is sometimes dosed in the afternoon to extend the duration of effect of a morning-dosed extended-release (ER) MPH for attenti...

01/19/2023

A Real-World Observational Study Design Comparing Vortioxetine With Standard of Care Monotherapy Treatments: Assessment of Patient Global Improvement, Goal Attainment, and Patient-Centric Measures in Major Depressive Disorder

Abstract: Aim: To gain insights on the real-world treatment experiences of patients with major depressive disorder (MDD) through PatientsLikeMe (PLM), an online community platform. The pr...

01/19/2023

Modeling Cost Savings Following Use of Pharmacogenetic Testing in a Regional Accountable Care Organization

Abstract: Pharmacogenetic testing (PGx) has been shown to decrease healthcare resource utilization in a variety of settings, including behavioral health1. We have developed a method to re...

01/19/2023

Long-Term Efficacy and Safety of Deutetrabenazine in Postmenopausal Women With Tardive Dyskinesia

Abstract: Introduction: Advanced age and female sex are risk factors for tardive dyskinesia (TD). This post hoc analysis assessed the long-term efficacy and safety of deutetrabenazine, an...

01/19/2023

Treatment Success and Psychiatric Stability in Adults with Tardive Dyskinesia: Post Hoc Analyses of Two Long-Term Valbenazine Studies

Abstract: Background: In clinical trials of valbenazine, which is approved for once-daily treatment of tardive dyskinesia (TD), psychiatric stability was assessed along with global change...

01/19/2023

Efficacy of Fremanezumab Quarterly and Monthly Dosing Regimens in Patients With Migraine and Psychiatric Comorbidities

Abstract: Introduction: Migraine with psychiatric comorbidities has been associated with increased disability, pain, and reduced quality-of-life.

01/19/2023

Fremanezumab for Preventive Migraine Treatment in Patients With Major Depressive Disorder: Baseline Patient Characteristics in the Phase 4 UNITE Study

Abstract: Introduction: Major depressive disorder (MDD) is a common migraine comorbidity. Fremanezumab, a humanized monoclonal antibody selectively targeting calcitonin gene-related pepti...

01/19/2023

Tracks

Major Depressive Disorder

General Psychiatry

ADHD

MDD Insights

Schizophrenia Insights

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.

December 9 ⁠–⁠ December 11

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

May 28 ⁠–⁠ May 31

See Full Calendar

poster

Tracks

About

Specialties

Events

Year Round Education

HMP Global Products